Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186743 · ClinicalTrials.gov registry record · NA
Irritable Bowel Syndrome and Food Sensitivity
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02186743 is a NA study that has completed, run by Yale University. The registered enrollment target is 58 participants.
The verdict
NCT02186743, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The primary objective of the clinical trial portion of this study is to assess whether an individualized dietary plan based on a commercial food sensitivity assay provides specific benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).
Interventions
- OTHER Personalized Dietary Advice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186743
The ClinicalTrials.gov registry entry for NCT02186743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Personalized Dietary Advice is the first listed.
NCT02186743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186743 about?
NCT02186743 is a clinical study titled "Irritable Bowel Syndrome and Food Sensitivity". The primary objective of the clinical trial portion of this study is to assess whether an individualized dietary plan based on a commercial food sensitivity assay provides specific benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).
What is the current status of trial NCT02186743?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2014-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02186743?
The interventions under investigation include: Personalized Dietary Advice (OTHER).
Who is sponsoring clinical trial NCT02186743?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.